APA (7th ed.) Citation

X, P., W, S., A, X., C, A., X, C., C, C., . . . C, L. (2020). Development of AAV Variants with Human Hepatocyte Tropism and Neutralizing Antibody Escape Capacity. Molecular therapy. Methods & clinical development, 18, 259. https://doi.org/10.1016/j.omtm.2020.06.003

Chicago Style (17th ed.) Citation

X, Pei, et al. "Development of AAV Variants with Human Hepatocyte Tropism and Neutralizing Antibody Escape Capacity." Molecular Therapy. Methods & Clinical Development 18 (2020): 259. https://doi.org/10.1016/j.omtm.2020.06.003.

MLA (9th ed.) Citation

X, Pei, et al. "Development of AAV Variants with Human Hepatocyte Tropism and Neutralizing Antibody Escape Capacity." Molecular Therapy. Methods & Clinical Development, vol. 18, 2020, p. 259, https://doi.org/10.1016/j.omtm.2020.06.003.